Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes

Inclusion Criteria: * Male or female * At least 6 years old * Diagnosed with type 1 or type 2 diabetes * Currently using a continuous glucose monitoring (CGM) sensor * CGM sensor usage time \< 70% over the last 4 months * HbA1c ≥ 8% (verified by blood test or capillary test, no older than one month at the time of enrollment) * Patient (or legal representative) owns a smartphone and has internet access (for completing questionnaires) * Patient is covered by a social security scheme * Patient (or legal representative, if applicable) is capable of reading and understanding the study procedure, and is able to give informed consent for participation in the study protocol Exclusion Criteria: * Patient with serious and untreated skin issues in the areas where the device will be applied (e.g., psoriasis, herpetiform dermatitis, skin rash, staphylococcal infection, etc.) * Patient currently participating or having participated in an interventional clinical study within the month prior to enrollment that may impact the study, as determined by the investigator * Patient or their legal representative who is deprived of liberty, under guardianship, or under curatorship. * Pregnant or breastfeeding women, or women of childbearing age without an effective method of contraception, or those who do not agree to continue using contraception throughout the study duration. (Pregnancy will be checked by a urine HCG test for any woman wishing to participate and of childbearing age (under 60 years old).